The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 levelIssam Ben Sahra, Frédéric Bost, Jean‐François Tanti et al.|Oncogene|2008Cited by 852
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1Isaam Ben Sahra, Frédéric Bost, Jean‐François Tanti et al.|Cancer Research|2011Cited by 620
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer CellsIssam Ben Sahra, Frédéric Bost, Jean‐François Tanti et al.|Cancer Research|2010Cited by 528
Inhibition of p38MAPK Increases Adipogenesis From Embryonic to Adult StagesMyriam Aouadi, Frédéric Bost, Y. Le Marchand‐Brustel et al.|Diabetes|2006Cited by 199